DeepMind will continue its health research and academic partnerships, but Google will now market and sell its products. Other DeepMind businesses will remain independent of Google.
One of DeepMind’s flagship health products is Streams, an app designed to help physicians deliver better, faster care to patients. The goal is to make Streams into an artificial intelligence-powered assistant for clinicians. At least 10 U.K. hospitals have signed deals to use the app.
“It has been a phenomenal journey to see Streams go from initial idea to live deployment, and to hear how it’s helped change the lives of patients and the nurses and doctors who treat them. I can’t think of a better person than Dr. David Feinberg to lead health efforts at Google, helping to make a difference to the lives of millions of patients around the world,” Mustafa Suleyman, co-founder and head of applied AI at DeepMind, wrote in a company blog post.
DeepMind’s health group employs more than 100 people, who will continue to work in its London offices and report to DeepMind health subsidiary’s clinical lead Dr. Dominic King, according to CNBC.
More articles on health IT:
Health First Florida phishing attack may have compromised 42,000 patients
600 providers weigh in on their information security backup systems
Saint Anthony Hospital selects GeBBS for HIM compliance audit & coding services